secwatch.observer — SEC 8-K summary
======================================

Issuer:     Syra Health Corp (SYRA)
CIK:        0001922335
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0001493152-24-018507
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Syra Health Q1 revenue up 47% to $1.7M, net loss widens to $1.4M; FY2024 guidance $9-11M
--------------------------------------------------------------------------------

- Revenue $1.7M vs $1.2M Q1 2023; Population Health grew 212% YoY; Healthcare Workforce up 28%.
- Net loss $(1.4M) vs $(0.8M); Adjusted EBITDA $(1.4M) vs $(0.8M).
- Gross margin 10.2% (12.4% Q1 2023) due to mix shift to Healthcare Workforce.
- Cash $3.2M, no long-term debt; FY2024 revenue guidance $9-11M (64-100% growth).
- Awarded contracts: $660K HEDIS, $480K Indiana, $450K Shelby County, $250K DC; active in 19 states.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1922335/000149315224018507/0001493152-24-018507-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1922335/000149315224018507/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-018507

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer